Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age

Ingerslev, 2001, A randomised study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate, Hum Reprod, 16, 696, 10.1093/humrep/16.4.696 Thornton, 1998, Immature oocyte retrieval, Fertil Steril, 70, 647, 10.1016/S0015-0282(98)00274-X Monks, 1993, Development of embryos from natural cycle in-vitro fertilization, Hum Reprod, 8, 266, 10.1093/oxfordjournals.humrep.a138035 Akman, 2000, Addition of GnRH antagonist in cycles of poor responders undergoing IVF, Hum Reprod, 15, 2145, 10.1093/humrep/15.10.2145 Abdalla, 1993, Age, pregnancy and miscarriage, Hum Reprod, 8, 1512, 10.1093/oxfordjournals.humrep.a138289 Meldrum, 1994, Successful pregnancies with unstimulated cycle oocyte donation using an antagonist of gonadotropin-releasing hormone, Fertil Steril, 61, 556, 10.1016/S0015-0282(16)56594-7 Popovic-Todorovic, 2003, A prospective study of predictive factors of ovarian response in ‘standard’ IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram, Hum Reprod, 18, 781, 10.1093/humrep/deg181 Paulson, 1989, In vitro fertilization in unstimulated cycles, Fertil Steril, 51, 1059, 10.1016/S0015-0282(16)60746-X Lenton, 1993, Natural-cycle versus stimulated-cycle IVF, J Assist Reprod Genet, 10, 406, 10.1007/BF01228090 Hojgaard, 2001, Friendly IVF. Patient opinions, Hum Reprod, 16, 1391, 10.1093/humrep/16.7.1391 Kol, 2000, Embryo implantation and GnRH antagonists. GnRH antagonists in ART, Hum Reprod, 15, 1881, 10.1093/humrep/15.9.1881 Mannaerts, 2000, GnRH antagonists do not activate the GnRH receptor, Hum Reprod, 15, 1882, 10.1093/humrep/15.9.1882 Rongieres-Bertrand, 1999, Revival of natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix), Hum Reprod, 14, 683, 10.1093/humrep/14.3.683 Foulot, 1989, In vitro fertilization without ovarian stimulation, Fertil Steril, 52, 617, 10.1016/S0015-0282(16)60974-3 Janssens, 2000, In-vitro fertilization in a spontaneous cycle, Hum Reprod, 15, 314, 10.1093/humrep/15.2.314 Cahill, 1998, Onset of the preovulatory luteinizing hormone surge, Fertil Steril, 70, 56, 10.1016/S0015-0282(98)00113-7 Diedrich, 1994, Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation, Hum Reprod, 9, 788, 10.1093/oxfordjournals.humrep.a138597 Hernandez, 2000, Embryo implantation and GnRH antagonists. Embryo implantation, Hum Reprod, 15, 1211, 10.1093/humrep/15.6.1211 Benadiva, 1997, Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome, Fertil Steril, 67, 724, 10.1016/S0015-0282(97)81373-8 Olivennes, 1998, The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer, Hum Reprod, 13, 2411, 10.1093/humrep/13.9.2411 Olivennes, 1995, Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles, Hum Reprod, 10, 1382 Lenton EA, Cooke ID, Hooper M, King H, Kumar A, Monks N, et al. In vitro fertilization in the natural cycle. Bailliere's Clin Obstet Gynaecol 1992;6,229–44 Nargund, 2001, Cumulative conception and life birth rates in natural (unstimulated) IVF cycles, Hum Reprod, 16, 259, 10.1093/humrep/16.2.259 Paulson, 1992, In vitro fertilization in unstimulated cycles, Fertil Steril, 57, 290, 10.1016/S0015-0282(16)54832-8